BMO Capital raised the firm’s price target on Legence (LGN) to $63 from $46 and keeps an Outperform rating on the shares. The company’s demand tailwinds that underpinned the strong growth in recent years appear set to continue over the intermediate term, the analyst tells investors in a research note. Execution has been solid and Legence has good relations with local unions, which allows the company to access labor resources to pursue growth opportunities, the firm adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Legence price target raised to $63 from $52 at Goldman Sachs
- Legence Corp. Delivers Record Results, Lifts 2026 Outlook
- Tigress Financial sees AI momentum powering gowth for Legence
- Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
- Morning Movers: AstraZeneca jumps following tozorakimab trial results